iBio (IBIO) Accumulated Depreciation (2018 - 2026)

iBio (IBIO) has reported Accumulated Depreciation for 9 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Depreciation rose 38.79% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 38.79% YoY), while the FY2025 annual figure was $1.5 million, up 47.87% from the prior year.
• Accumulated Depreciation advanced to $1.9 million in Q1 2026 per IBIO's latest filing, from $1.8 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $1.9 million in Q1 2026 and bottomed at $115000.0 in Q4 2022.
• Historically, Accumulated Depreciation has averaged $1.0 million across 5 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2023 — Accumulated Depreciation surged 533.91% — and 2026, when it jumped 38.79%.
• iBio's Accumulated Depreciation stood at $115000.0 in 2022, then soared by 533.91% to $729000.0 in 2023, then jumped by 71.88% to $1.3 million in 2024, then jumped by 40.38% to $1.8 million in 2025, then advanced by 8.41% to $1.9 million in 2026.
• Business Quant data shows IBIO's Accumulated Depreciation at $1.9 million in Q1 2026, $1.8 million in Q4 2025, and $1.6 million in Q3 2025.